# The impact of comorbidity burden on outcomes following endovascular thrombectomy for acute ischemic stroke: A nationwide prospective observational study

**Authors:** Emma Hall, Björn Hansen, Mats Pihlsgård, Magnus Esbjörnsson, Bo Norrving, Teresa Ullberg, Johan Wassélius

PMC · DOI: 10.1093/esj/23969873251332136 · European Stroke Journal · 2026-01-01

## TL;DR

This study shows that patients with more health issues have worse outcomes after stroke treatment, but successful treatment can still help them regain independence.

## Contribution

The study provides real-world evidence on how comorbidity levels affect outcomes of endovascular thrombectomy in stroke patients.

## Key findings

- Higher comorbidity burden is linked to lower odds of favorable outcomes after endovascular thrombectomy.
- Successful recanalization improves functional outcomes across all comorbidity levels.
- Patients with severe comorbidities face higher complication risks during and after the procedure.

## Abstract

Patients with substantial comorbidity burden are underrepresented in clinical trials on endovascular thrombectomy (EVT), despite being common in clinical routine care. Therefore, analysis of observational data is needed to evaluate how increasing comorbidity burden affects procedural success rate, complication rate, and clinical outcome following EVT.

We conducted a register-based observational study involving pre-stroke functionally independent patients treated with EVT in Sweden 2015–2021. Comorbidity burden was assessed using the Charlson Comorbidity Index (CCI) and categorized as no (CCI 0), moderate (CCI 1), severe (CCI 2), and very severe (CCI ⩾3). The primary outcome was favorable 90-day outcome (modified Rankin Scale 0–2). Secondary outcomes included successful recanalization, and peri- and postoperative complications.

Of 4735 included patients, 40% had no comorbidity (CCI 0), 15% had moderate (CCI 1), 21% had severe (CCI 2), and 24% had very severe comorbidity burden (CCI ⩾3). The yearly proportion of patients with very severe comorbidity burden increased from 16% to 30% during the study period. Increasing comorbidity levels were associated with decreased odds ratio (OR) of favorable outcome compared to patients without comorbidity: CCI 1 adjusted OR (aOR) 0.64, 95% CI 0.57–0.85; CCI 2 aOR 0.59, 95% CI 0.47–0.74; and CCI ⩾3 aOR 0.38, 95% CI 0.30–0.47, but there were no significant differences in successful recanalization rates. Patients with CCI 2 had higher OR for perioperative and postoperative complications (OR 1.43, 95% CI 1.09–1.88, and OR 1.41, 95% CI 1.15–1.71), and patients in the CCI ⩾3 group had higher OR of postoperative complications (OR 1.34, 95% CI 1.14–1.67), compared to patients in the CCI 0 group. Successful recanalization was associated with favorable functional outcome in all CCI-groups.

Severe and very severe comorbidity burden are increasingly common among EVT-treated patients in routine healthcare and are linked to poorer outcomes. However, our results suggest that successful EVT is associated with functional independency, also in patients with severe and very severe comorbidity burden.

Graphical abstract

## Full-text entities

- **Diseases:** stroke (MESH:D020521), ischemic stroke (MESH:D002544)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12866226/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12866226/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12866226/full.md

---
Source: https://tomesphere.com/paper/PMC12866226